SPARC gene polymorphism in renal transplant patients with gingival overgrowth

Journal of Periodontology

Volumn 78, Issue 11, 2007, Pages 2185-2189

  Drozdzik, A ^a   Kurzawski, M ^a   Kozak, M ^a   Banach, J ^a   Drozdzik, Marek ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Gingival overgrowth; Organ transplantation; Polymorphism; SPARC

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; OSTEONECTIN;

ADULT; AGED; ALLELE; ARTICLE; CHEMICALLY INDUCED DISORDER; EPIDEMIOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GINGIVA OVERGROWTH; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

ADULT; AGED; ALLELES; CYCLOSPORINE; EPIDEMIOLOGIC METHODS; FEMALE; GENE FREQUENCY; GENOTYPE; GINGIVAL OVERGROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OSTEONECTIN; POLYMORPHISM, GENETIC;

EID: 36348990151     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.070115     Document Type: Article

References (34)

1. Somacarrera ML, Hernandez G, Acero J, Moskow BS. Factors relating to the incidence and severity of cyclosporine-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994; 65:671-675.
2. Margiotta V, Pizzo I, Pizzo G, Barbaro A. Cyclosporine-and nifedipine-induced gingival overgrowth in renal transplant patients: Correlations with periodontal and pharmacological parameters, and HLA-antigens. J Oral Pathol Med 1996;25:128-134.
3. Marshall RI, Bartold PM. A clinical review of drug-induced gingival overgrowth. Aust Dent J 1999;44:219-232.
4. Afonso M, de Oliveira Bello V, Shibli JA, Sposto MR. Cyclosporine A-induced gingival overgrowth in renal transplant recipients. J Periodontol 2003;74:51-56.
5. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
6. Thomas DW, Baboolal K, Subtamanian N, Newcombe RG. Cyclosporine A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. J Clin Periodontol 2001;28:706-709.
7. Thomas DW, Newcombe RG, Osborne G. Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 2000;69:552-556.
8. Bradshaw AD, Sage EH. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 2001;107:1049-1054.
9. Brekken RA, Sage EH. SPARC, a matricellular protein: At the crossroads of cell-matrix communication. Matrix Biol 2001;19:816-827.
10. Bradshaw AD, Graves DC, Motamed K, Sage EH. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci USA 2003;100:6045-6050.
11. Salonen J, Domenicucci C, Goldberg HA, Sodek J. Immunohistochemical localization of SPARC (osteonectin) and denatured collagen and their relationship to remodelling in rat dental tissues. Arch Oral Biol 1990;35:337-346.
12. Gagliano N, Moscheni C, Torri C, et al. Differential effect of cyclosporin A and FK506 on SPARC mRNA expression by human gingival fibroblasts. Biomed Pharmacother 2005;59:249-252.
13. James JA, Boomer JJ, Maxwell AP, et al. Reduction in gingival overgrowth associated with conversion from cyclosporine A to tacrolimus. J Clin Periodontol 2000; 27:144-148.
14. Zhou X, Tan FK, Reveille JD, et al. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum 2002;46:2990-2999.
15. Lagan AL, Pantelidis P, Renzoni EA, et al. Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma. Rheumatology 2005;44:197-201.
16. Pernu HE, Pernu HM, Huttunen KR, Nieminen PA, Knuuttila ML. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63:548-553.
17. Drozdzik M, Mysliwiec K, Lewinska-Chelstowska M, Banach J, Drozdzik A, Grabarek J. P-glycoprotein drug transporter MDR-1 gene polymorphism in renal transplant patients with gingival overgrowth. J Clin Periodontol 2004;31:758-763.
18. Drozdzik M, Kurzawski M, Drozdzik A, Kotrych K, Banach J, Pawlik A. Interleukin-6 gene polymorphism in renal transplant patients with and without gingival overgrowth. J Clin Periodontol 2005;32:955-958.
19. Kurzawski M, Drozdzik A, Dembowska E, Pawlik A, Banach J, Drozdzik M. Matrix metalloproteinase-1 gene polymorphism in renal transplant patients with and without gingival enlargement. J Periodontol 2006; 77:1498-1502.
20. Ogino M, Kido J, Bando M, et al. Alpha 2 integrin +807 polymorphism in drug-induced gingival overgrowth. J Dent Res 2005;84:1183-1186.
21. Radwan-Oczko M, Boratynska M, Zietek M, Zoledziewska M, Jonkisz A. The relationship of transforming growth factor-beta1 gene polymorphism, its plasma level, and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens. J Periodontol 2006;77:865-873.
22. Bostanci N, Ilgenli T, Pirhan DC, et al. Relationship between IL-1A polymorphisms and gingival overgrowth in renal transplant recipients receiving cyclosporin A. J Clin Periodontol 2006;33:771-778.
23. Ellis JS, Morgan CL, Kirby JA, Taylor JJ, Thomason JM. Plasma TGF-beta1 as a risk factor for gingival overgrowth. J Clin Periodontol 2004;31:863-868.
24. McGaw WT, Porter H. Cyclosporin-induced gingival overgrowth: An ultrastructural stereologic study. Oral Surg Oral Med Oral Pathol 1988;65:186-190.
25. Tremble PM, Lane TF, Sage EH, Werb Z. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces the expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 1993;121: 1433-1444.
26. Cao Z, Li C, Zhu G. MMP-1 promoter gene polymorphism and susceptibility to chronic periodontitis in a Chinese population. Tissue Antigens 2006;68:38-43.
27. Keles GC, Gunes S, Sumer AP, et al. Association of matrix metalloproteinase-9 promoter gene polymorphism with chronic periodontitis. J Periodontol 2006; 77:1510-1514.
28. Astolfi CM, Shinohara AL, da Silva RA, Santos MC, Line SR, de Souza AP. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. J Clin Periodontol 2006;33:699-703.
29. Holla LI, Fassmann A, Muzik J, Vanek J, Vasku A. Functional polymorphisms in the matrix metalloproteinase-9 gene in relation to severity of chronic periodontitis. J Periodontol 2006;77:1850-1855.
30. Porter PL, Sage EH, Lane TF, Funk SE, Gown AM. Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem 1995;43:791-800.
31. McKaig SJ, Kelly D, Shaw L. Investigation of the effect of FK506 (tacrolimus) and cyclosporine on gingival overgrowth following paediatric liver transplantation. Int J Paediatr Dent 2002;12:398-403.
32. Busque S, Demers P, St-Louis G, Boily JG, Tousignant J, Lemieux F. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. Transplant Proc 1998;30:1247-1248.
33. Wilson RF, Morel A, Smith D, et al. Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy. J Clin Periodontol 1998;25:457-464.
34. Thomason JM, Ellis JS, Kelly PJ, Seymour RA. Nifedipine pharmacological variables as risk factors for gingival overgrowth in organ-transplant patients. Clin Oral Investig 1997;1:35-39.